GPCRs Revisited: New Insights Lead to Novel Drugs

By Eglen Richard M.   Reisine Terry  

Pharmaceuticals, Vol. 4, Iss. 2, 2011-01 ,pp. : 244-272

MDPI

Access to resources Recommend Favorite

The Historical Development of Immunoendocrine Concepts of Psychiatric Disorders and Their Therapy

By Steinberg Holger   Kirkby Kenneth C.   Himmerich Hubertus  

International Journal of Molecular Sciences, Vol. 16, Iss. 12, 2015-12 ,pp. : 28841-28869

MDPI

Access to resources Recommend Favorite

CK2—An Emerging Target for Neurological and Psychiatric Disorders

By Castello Julia   Ragnauth Andre   Friedman Eitan   Rebholz Heike  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-01 ,pp. : 7-7

MDPI

Access to resources Recommend Favorite

Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders

By Kubota Takeo   Takae Hirasawa   Miyake Kunio  

Pharmaceuticals, Vol. 5, Iss. 4, 2012-04 ,pp. : 369-383

MDPI

Access to resources Recommend Favorite

PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders

By Palomer Xavier   Barroso Emma   Pizarro-Delgado Javier   Peña Lucía   Botteri Gaia   Zarei Mohammad   Aguilar David   Montori-Grau Marta   Vázquez-Carrera Manuel  

International Journal of Molecular Sciences, Vol. 19, Iss. 3, 2018-03 ,pp. : 913-913

MDPI

Access to resources Recommend Favorite